InvestorsHub Logo
Followers 37
Posts 2960
Boards Moderated 0
Alias Born 01/14/2003

Re: Bill B post# 291239

Thursday, 08/13/2020 11:15:02 PM

Thursday, August 13, 2020 11:15:02 PM

Post# of 425648
Ronan lambe and John climax

https://www.businesswire.com/news/home/20180727005016/en/ICON-Confirms-Retirement-Co-Founder-Dr.-Ronan-Lambe

During the fiscal year ending May 31, 2005, Amarin contracted ICON Clinical Research Limited (a wholly owned subsidiary of ICON), to conduct a clinical trial on its behalf. The total potential value of this study is $7 million. During the year ended December 31, 2008, the Company recognized $0.2 million of revenue relating to the Amarin contract. At December 31, 2008, $0.3 million was outstanding to be received from Amarin on this trial.

http://www.sec.gov/Archives/edgar/data/1060955/000118811209000777/t64807_20f.htm


It's the ratio, baby ... the EPA/AA ratio!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News